Serum albumin levels decreased in patients with IP over the observation period (P = 0.0185; Wilcoxon signed-rank test), but serum albumin levels in patients with COPD and those with CHF did not change. This evidence concerns the gene ALB and chronic obstructive pulmonary disease.